Trial NCT04874831

View at ClinicalTrials.gov 
Org. Study IDs: 4SC-202-4-2019
Secondary IDs: 2019-003575-19

Last trial update was posted on 2021-11-18

MeSH Interventions

Avelumab

MeSH Conditions

Carcinoma Carcinoma, Merkel Cell

Other Conditions

Merkel Cell Carcinoma

Stopping Reasons

Refocusing of sponsor's clinical development program. No safety concern or change of the risk-benefit assessment of the investigational medicinal product has led to this decision.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID